کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
8737724 1591372 2017 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
The ERAP gene is associated with HCV chronic infection in a Chinese Han population
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی ایمونولوژی
پیش نمایش صفحه اول مقاله
The ERAP gene is associated with HCV chronic infection in a Chinese Han population
چکیده انگلیسی
Endoplasmic reticulum aminopeptidases (ERAPs), ERAP1 and ERAP2, are critical components in the antigen-presentation system and are specialized to produce optimal-sized peptides for HLA I binding. ERAP gene polymorphisms have been correlated with HLA-associated diseases. To investigate the association between ERAP gene polymorphisms and HCV chronic infection, a TaqMan assay was used to genotype 4 SNPs (rs27044, rs30187, rs26618 and rs26653) in ERAP1 and 2 SNPs (rs2248374 and rs2549782) in ERAP2 genes in 376 Chinese Han HCV chronic infections and 324 healthy Chinese Han controls. The allelic distribution of rs26618 in the ERAP1 gene and rs2248374 in ERAP2 gene were both significantly different in case and control groups. The C-allele of rs26618 had an increased HCV chronicity risk compared with the T-allele (P = .025, OR = 1.318, 95%CI: 1.035-1.677), and the same effect was found in A-allele of rs2248374 compared with G-allele (P = 0.046, OR = 1.244, 95%CI: 1.004-1.540). There were notable differences in the genotype distribution in analysis using the dominant genetic model in rs26618 (CC + CT vs. TT; P = 0.007, OR = 1.473, 95%CI: 1.091-1.989) and recessive genetic model in rs2248374 (AA vs. AG + GG; P = 0.003, OR = 1.548, 95%CI: 1.026-2.335). In addition, rs26618 and rs2248374-genotype combination played noteable effects on the clinical parameters. These results indicated that the ERAP gene may play a critical role in HCV chronicity in this Chinese Han population.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Human Immunology - Volume 78, Issues 11–12, November 2017, Pages 731-738
نویسندگان
, , , , , , , , , , ,